Patent · US Expired

Rapamycin assay

US6635745B2 · kind B2 · utility

10Cited by

16References

4Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Richard Sedrani · Basel, CH
Valerie Ryffel · Allschwil, CH

Key dates

Filing date	Jan 9, 2001
Grant date	Oct 21, 2003
Priority date	—
Expiry date	Jan 28, 2021

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K16/1292
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Monoclonal antibodies to rapamycin and to 40-O-alkylated derivatives of rapamycin are provided, together with novel haptens, immunogenic conjugates, and processes for making them and assay kits for using them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.